Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.340
-0.040 (-1.68%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Organogenesis Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 92.1 | 94.33 | 136.15 | 104.34 | 103.29 | 114.53 |
Cash & Short-Term Investments | 92.1 | 94.33 | 136.15 | 104.34 | 103.29 | 114.53 |
Cash Growth | -16.68% | -30.72% | 30.49% | 1.01% | -9.81% | 35.05% |
Accounts Receivable | 116.91 | 217.45 | 109.86 | 82 | 89.45 | 82.46 |
Inventory | 28.43 | 29.63 | 26.22 | 28.25 | 24.78 | 25.02 |
Other Current Assets | 31.07 | 20.78 | 13.71 | 10.45 | 5.09 | 4.97 |
Total Current Assets | 268.5 | 362.19 | 285.94 | 225.04 | 222.61 | 226.98 |
Net Property, Plant & Equipment | 157.82 | 159.46 | 126.24 | 156.35 | 145.66 | 128.3 |
Other Intangible Assets | 3.44 | 9.15 | 12.47 | 15.87 | 20.79 | 25.67 |
Goodwill | 28.77 | 28.77 | 28.77 | 28.77 | 28.77 | 28.77 |
Other Long-Term Assets | 61.46 | 39.17 | 44.47 | 33.99 | 31.53 | 33.53 |
Total Assets | 519.99 | 598.73 | 497.89 | 460.03 | 449.36 | 443.26 |
Accounts Payable | 37.68 | 49.53 | 39.45 | 30.72 | 32.33 | 29.34 |
Accrued Expenses | - | - | - | 30.07 | 26.45 | 37.29 |
Current Portion of Long-Term Debt | 0.51 | 9.44 | 1.17 | 5.49 | 4.54 | 4.09 |
Current Portion of Leases | 37.83 | 41.16 | 36.85 | 14.23 | 11.71 | 11.99 |
Total Current Liabilities | 76.02 | 100.12 | 77.48 | 80.51 | 75.02 | 82.71 |
Long-Term Debt | 12.36 | 12.79 | 0.72 | 60.75 | 66.23 | 70.77 |
Long-Term Leases | 48.78 | 36.52 | 47.67 | 38.9 | 41.31 | 46.89 |
Other Long-Term Liabilities | 1.49 | 1.19 | 0.89 | 1.21 | 1.12 | 1.56 |
Total Long-Term Liabilities | 62.62 | 50.5 | 49.28 | 100.85 | 108.67 | 119.22 |
Total Liabilities | 138.65 | 164.81 | 112.57 | 181.36 | 183.69 | 201.92 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 300.78 | 303.19 | 302.99 | 319.62 | 310.96 | 302.16 |
Retained Earnings | -56.23 | -3.08 | -40.11 | -40.97 | -45.3 | -60.83 |
Total Common Shareholders' Equity | 244.56 | 300.13 | 262.9 | 278.66 | 265.67 | 241.34 |
Minority Interest | 136.79 | 133.79 | 122.42 | - | - | - |
Shareholders' Equity | 381.35 | 433.92 | 385.32 | 278.66 | 265.67 | 241.34 |
Total Liabilities & Equity | 519.99 | 598.73 | 497.89 | 460.03 | 449.36 | 443.26 |
Total Debt | 99.48 | 99.9 | 86.41 | 119.35 | 123.79 | 133.74 |
Net Cash (Debt) | -7.38 | -5.57 | 49.74 | -15.01 | -20.5 | -19.21 |
Net Cash Per Share | -0.06 | -0.04 | 0.38 | -0.11 | -0.15 | -0.14 |
Book Value | 244.56 | 300.13 | 262.9 | 278.66 | 265.67 | 241.34 |
Book Value Per Share | 1.89 | 2.30 | 2.00 | 2.10 | 2.01 | 1.81 |
Tangible Book Value | 212.35 | 262.21 | 221.66 | 234.02 | 216.11 | 186.89 |
Tangible Book Value Per Share | 1.64 | 2.01 | 1.68 | 1.76 | 1.63 | 1.40 |